Apoptotic cell death plays an important role in the cascade of neuronal degeneration after traumatic brain injury (TBI), but the underlying mechanisms are not fully understood.
1994; Hicks et aI., 1996) , Studies also show that TBI may induce apoptosis (i.e" programmed cell death; for review see McIntosh et aI., 1998) . In contrast to necrosis, a cell undergoing apoptosis is characterized by uniform internucleosomal DNA fragmentation, nuclear shrink age, chromatin compaction as well as by cytoplasmatic condensation, and disintegration (for reviews see Kerr et aI., 1972; Bredesen, 1995) .
Although apoptotic neuronal cell death has been sug gested to play an important role for neurodegeneration after TBI, little is known about the intracellular cascade that leads to the induction of apoptosis after acute ex perimental brain injuries in vivo. However, evidence shows that the interaction between the Fas/APO (apop tosis )-l/CD95 molecule with its ligand (Fas ligand, FasL) may induce programmed cell death (for review see Becher et aI., 1998) .
Fas, a type I 48-kDa transmembrane receptor glyco protein is a member of the nerve growth factor/tumor necrosis factor receptor superfamily of surface molecules whose members have a wide range of functions related to cell survival, differentiation, and immune responses. Li gation of Fas by its natural ligand, FasL, a type II mem brane protein belonging to the tumor necrosis factor (TNF) family, or by agonistic anti-Fas monoclonal anti body, rapidly induces apoptosis in sensitive cells. In ad dition, it has been demonstrated that FasL-induced ap optosis involves the activation of death proteases of the caspase family (for review see Nagata, 1997) .
Few data exist on the involvement of Fas/FasL in apoptotic cell death in acute and chronic CNS diseases, respectively. For example, Fas is overexpressed in neu ral-derived tumors (Tachibana et aI., 1996) and is asso ciated with apoptosis in neuroblastoma cells (Bernassola et aI., 1999) . In addition, reports identify Fas in adult postmortem brains of patients with neurodegenerative disorders including Alzheimer's disease (Nishimura et aI., 1995) and multiple sclerosis (D'Souza et aI., 1996; Bonetti and Raine, 1997) . Further, intrathecal release of Fas has been observed in patients with bacterial menin gitis (Fassbender et aI., 1999) and in patients with acute ischemic stroke (Tarkowski et aI., 1999) . Moreover, Fas messenger RNA (mRNA) also is expressed in periven tricular cells in postischemic adult mouse brains (Mat suyama et aI., 1994) . Last, a report provides evidence that overexpression of FasL may induce apoptosis after experimental brain ischemia in the rat (Martin-Villalba et aI., 1999) .
Despite increasing evidence that Fas and FasL may have a potential role for inducing apoptosis in cerebral ischemia and chronic CNS diseases, little is known about the expression of Fas and FasL after TEl in vivo. Only one report provides evidence that FasL is overexpressed in CSF of patients after severe head injury (Ertel et aI., 1997) . To further investigate potential changes of Fas and FasL expression after experimental TBI, rodents were subjected to a widely used model of experimental mechanical brain injury: lateral cortical impact injury (Dixon et aI., 199 1) . The current study used Western blot analyses of cortical and hippocampal samples to deter mine the temporal profile of Fas and FasL protein changes from 15 minutes to 14 days after experimental TBI. Further, immunohistochemical examinations were performed to investigate the cellular distribution of Fas and FasL expression after TBI in vivo.
MATERIALS AND METHODS

Rat model of traumatic brain injury
A controlled cortical impact device was used to induce a moderate level of TBl, as described previously (Dixon et aI., 199 1; Kampfl et aI., 1996; Franz et al.. 1999; Zhao et aI.. 1998) .
Briefly. adult male Sprague-Dawley rats (250 to 350 g) were intubated and anesthetized with 2% halothane in a 2: I mixture of N20/02. Core body temperature was monitored continu-J eaeh Blood Flow Metab. Vol. 20, No. 4, 2000 ously by a rectal thermistor probe and maintained at 37° to 38°C. Animals were mounted in a stereotaxic frame on the injury device in a prone position secured by ear and incisor bars. The head was held in a horizontal plane with respect to the interaural lines. A midline incision was made. the soft tissues reflected. and two 7-mm craniotomies were made between lambda and bregma and centered 5 mm laterally on either side of the central suture. The dura was kept intact over the cortex.
Injury was induced by impacting the right cortex (ipsilateral cortex) with a 6-mm diameter tip at a rate of 4 m/s. The injury device was set to produce a tissue deformation of 2 mm. Ve locity was measured directly by the linear velocity displace ment transducer (Shaevitz Model 500 HR. Detroit. MI. U.S.A.).
which produces an analog signal that was recorded by a PC based data acquisition system for analysis of time/displacement parameters of the impactor. After cortical impact, animals were extubated and immediately assessed for recovery of reflexes (Dixon et aI., 199 I) . Sham-injured animals underwent identical surgical procedures but did not receive impact injury. Naive animals were not exposed to any injury-related surgical proce dures. Sixty-four animals were used in this study (naive, n = 4; sham-injured rats, n = 4; injured rats. n = 56). All animal studies carefully conformed to the guidelines outlined in the 
Immunohistochemistry
Animals from all treatment groups (n = 32) were given a lethal injection of phenobarbital (20 mg/kg intraperitoneally) before perfusion. Rats were transcardially perfused through the left ventricle (120 mL of 0.9% saline and 200 mL of 4% para formaldehyde) at 15 minutes, 6 hours, 24 hours, 48 hours, 72 hours, 7 days, and 14 days after TEl (n = 4 for each time point after injury; n = 2 for sham and naive animals). Sham animals were killed at 15 minutes and 48 hours after sham surgery, respectively. The brains then were removed, grossly sectioned coronally at 2-mm intervals, and routinely embedded in paraf fin. Sections were then cut at 3 to 4 f.Lm on a rotary microtome, mounted on aminoalkylsilated glass slides, and processed for immunohistochemical staining as follows: Deparaffinized and rehydrated sections were microwaved for 15 minutes in 10 mmollL sodium citrate buffer, pH 6.0, and allowed to cool to RT. Endogenous peroxidase was blocked by treatment with 0.3% H202 in methanol followed by incubation with 10% fetal (Debus et aI., 1983) or an anti-ED 1 monoclonal antibody (Serotec, Kidlington, U.K.) (Graeber et aI., 1990) were used, respectively. All anti-bodies were diluted 1:500 in 10% FCS in PBS and allowed to bind overnight a 4°C. After being rinsed, sections were incu bated with a biotinylated horse anti-mouse antibody (Vector Laboratories) followed by avidin-peroxidase (Sigma) for 1 hour at RT. The reaction was visualized by treatment with 0.05% 3,3-diaminobenzidine tetrahydrochloride solution in PBS containing 0.05% H:P2' The color reaction was stopped with several washes of PBS. Sections were dehydrated through graded ethanol, cleared in a xylene substitute (Histoclear, Na tional Diagnostics, Atlanta, GA, U.S.A.), mounted in Permount (Fisher Scientific, Nepean, Ontario, Canada), and coverslipped.
Control sections without primary antibody did not stain.
Histochemical detection of DNA fragmentation
(terminal deoxynucleotidyl transferase-mediated deoxyuridine-biotin nick end labeling)
Terminal deoxynucleotidyl transferase (TdT)-mediated de oxyuridine-biotin nick end labeling (TUNEL) was performed as described by Gavrieli et al. (1992) with minor modifications.
Briefly, for double-label experiments, dewaxed and rehydrated sections of all animal groups from regions -1 .5 to -3.4 mm bregma were pretreated with 5% proteinase K in 10 mmollL Tris/HCl for 15 minutes at 37°C. After two washes in PBS, sections were incubated with blocking solution (0.3% H202 in methanol), rinsed twice, and permeabilized with 0.1 % Triton X-100 in 0.1 % sodium citrate for 2 minutes at 4°C. This was followed by incubation with labeling mix (Ix TdT buffer con taining 100 U/mL TdT and 20 nmol/L . mL biotin-conjugated 16 deoxyuridine) in a humidified chamber for 90 minutes at 37°C. After three washes in PBS, slides were incubated in Converter-POD for 10 minutes in a humidified chamber at 37°C. All reagents were purchased from Boehringer Mannheim. The reaction was visualized by treatment for 3 minutes with 0.05% 3,3-diaminobenzidine tetrahydrochloride solution in PBS containing 0.05% H202. Sections then were processed for Fas and FasL immunohistochemical study as de scribed earlier. Primary antibody, labeling mix, or secondary antibody were omitted in control sections. Sections were ex amined under the light microscope.
Statistical analysis
Western blotting band densities were quantified with com puter-assisted two-dimensional densitometric scanning on a 
RESULTS
Western blotting
Fas appeared as an immunoreactive band at approxi mately 45 kDa (Fig. lA) . Cortical impact injury resulted in an increase of Fas immunoreactivity in the ipsilateral 672 R. BEER ET AL. protein expression after trau matic brain inju ry (T BI). Samples from single control (sham) and single injured ani mals were prepared for West ern blotting at 15 minutes to 14 days after TBI. Levels of pro tein are expressed as arbitrary densitometric units. Data were transformed to percentages of the densitometric levels ob served on scans from sham animals visualized on the same blot. Values given are mean ± SO of four indepen dent experiments. +P < 0.05, ++P< 0.01, +++P< 0.001 rela tive to sham. (A) Ipsilateral cortex: Fas immunoreactivity increased significantly at 15 minutes (+P < 0.05) after TBI and peaked at 24 hours after injury (+++P < 0.001). Fas immunoreactivity still was significantly increased up to 72 hours after trauma (++P < 0.01). (8) Ipsilateral cortex: A significant increase in FasL protein was seen at 15 minutes after injury (+P < 0.05). Expression of FasL peaked at 48 hours after TBI (+++P < 0.001) and still was significantly elevated at 72 hours after impact injury (+++P < 0.001).
cortex. Ipsilateral Fas immunoreactiVity from injured animals increased by 275% relative to sham levels at 15 minutes after TBI (Fig. lA) . The increase in Fas immu noreactivity reached a maximum level by 24 hours after TBI (940% increase relative to sham animals) and declined to a 390% increase relative to sham at 72 hours after TBI. At 7 and 14 days after the injury, no statistical significant difference in Fas protein expression was ob served between cortical samples ipsilateral to the injury site and cortical samples from sham injured animals.
Western blot analysis for FasL indicated the presence of two immunoreactive bands at approximately 37 kDa ( Fig. lB) , probably from different glycosylated isoforms (Suda et aI., 1993; Runic et aI., 1996) . In the ipsilateral cortex, FasL levels were significantly higher from J 5 minutes to 72 hours after injury compared with control (sham) animals (Fig. IB) . In the ipsilateral cortex, FasL immunoreactivity increased within J 5 minutes after in jury (290% increase relative to sham levels), peaked at 48 hours after TBI with an increase of 2020% relative to sham animals, and slowly decreased thereafter to a level of 1890% relative to controls at 72 hours after trauma.
No significant differences were observed in Fas and FasL immunoreactivity between naive and sham-injured animals (data not shown). In addition, no significant changes in Fas and FasL protein expression were seen between sham and injured animals in cortical samples contralateral to the injury site and hippocampal samples ipsilateral and contralateral to the injury site at 15 min utes to 14 days after TEl (data not shown).
Immunohistochemical studies
Ipsilateral and contralateral cortical and hippocampal tissues were examined rostrocaudally from +0. . Fas immunoreactivity was observed in the ipsi lateral cortex at the primary injury zone (-1.5 to -3.4 mm bregma) from 15 minutes to 72 hours after the trauma (Fig. 2C ; time point 48 hours after trauma). Fas immunoreactivity was seen primarily in the soma of CNS cells (Fig. 2C ) in cortical layers 1 to 5. To further investigate if Fas is expressed in glial or neuronal cells, we performed double-labeling experiments for Fas, the neuronal cell-specific marker N euN, the astrocytic marker GFAP, and the microglial marker EDI. These immunohistochemical analyses of Fas-positive cells from 15 minutes to 72 hours after TBI (Figs. 2E and 2F; time point 48 hours after trauma) identified labeling with NeuN and GFAP and demonstrated the expression of Fas in cortical neurons ( Fig. 2E ) and astrocytes (Fig. 2F) , respectively. In contrast to late time points after impact injury (i.e., 24 hours to 72 hours after TBI), only few astrocytes and neurons were immunoreactive for Fas at 15 minutes after the trauma (data not shown). No Fas immunoreactivity was detected in microglial cells (data not shown).
Cells positive for FasL were seen in the ipsilateral cortex from IS minutes to 72 hours after the trauma. Similar to Fas, prominent FasL labeling was seen in the somata of CNS cells ( Fig. 2D ; time point 48 hours after impact injury) in the impact zone in cortical layers 1 to 5. In contrast to our Fas experiments, double-labeling investigations (Figs. 2H to 2J; time point 48 hours after TEl) provided evidence that FasL is expressed in neu rons (Fig. 2H) , astocytes (Fig. 21) , and microglial cells ( Fig. 2J) . At 15 minutes after the impact, only few as trocytes and neurons were immunoreactive for FasL. By 24 hours to 72 hours after TBI, the number of FasL immunopositive neurons, astrocytes, and microlgial cells had increased unambiguously (data not shown).
To verify further an apoptotic component of posttrau matic cell death, we used TUNEL staining technique on tissue sections from injured or control rat brains. The TUNEL-positive cells were detected in the ipsilateral cortex in layers 1 to 5 from 6 hours to 72 hours after injury (data not shown). No TUNEL-positive cells were observed in sham-operated animals, in the ipsilateral and contralateral hippocampus and in the contralateral cortex at all time points investigated (data not shown). To fur ther support the possibility that Fas and FasL mediate trauma-induced apoptosis, we performed double-labeling experiments using TUNEL and Fas (Fig. 2G) and FasL (Fig. 2K ) immunohistochemical studies. Double staining clearly demonstrated that TUNEL-positive cells with condensed and fragmented nuclei (Figs. 2J and 2K, ar rows) also expressed Fas (Fig. 2G) and FasL (Fig. 2K) in the ipsilateral cortex at 48 hours after TBI.
Immunoreactivity for Fas and FasL was absent in con tralateral cortical samples and hippocampal samples ip-674 R. BEER ET AL. silateral and contralateral to the injury site at all time points investigated (data not shown).
DISCUSSION
This study provides first evidence that Fas and FasL are overexpressed in the cortex after TBI in the rat. In the cortex ipsilateral to the injury site, increased Fas immu noreactivity was detected from IS minutes to 72 hours after the trauma. Fas immunolabeling was observed at similar time points after injury in cortical neurons and astrocytes. Cortical samples ipsilateral to the injury site also revealed a significant overexpression of FasL pro tein from IS minutes up to 72 hours after trauma. In contrast to the immunohistochemical results of Fas ex pression in the cortex, cortical neurons, astrocytes, and microglial cells were FasL immunopositive after impact injury. In addition, our TUNEL findings, as well as Fas and FasL immunohistochemical findings, implied that enhanced expression of Fas and FasL is involved in the apoptotic program of CNS cells in the ipsilateral cortex after TBI in vivo. In contrast, no expression of Fas and FasL were detected in cortical tissue contralateral to the injury site, and in ipsilateral and contralateral hippocam pal tissues from IS minutes to 14 days after impact in jury.
Histologic and biochemical features of apoptotic cell death have been reported after experimental TBI. For example, reports provide evidence that posttraumatic ap optosis, as demonstrated by DNA fragmentation and TUNEL staining, is seen after experimental lateral fluid percussion (FP) injury (Rink et aI., 1995; Yakovlev et aI., 1997; Conti et al. 1998 ) and cortical impact injury (Co1i cos and Dash, 1996; Co1icos et aI., 1996; Newcomb et aI., 1999) . In addition, gene expression associated with apoptosis has been studied. For example, alterations in the Bcl-2 gene family, which appear to be an important factor in mediating trauma-induced cell death, have been observed after FP injury (Raghupathi et aI., 1997) and controlled cortical impact (Clark et aI., 1997) . Further, current studies on caspase 3 expression, a cysteine pro tease that has been associated with the final steps in the apoptotic cascade, suggest a strong link between caspase activation and neuronal apoptosis after FP injury (Yak ovlev et aI., 1997; LaPlaca et aI., 1999) and controlled cortical impact (Pike et aI., 1998) 
Although the potential role for apoptosis in neuronal cell death after TBI has been suggested, the molecular and cellular mechanisms underlying the induction of apoptotic cell death after acute brain injuries remain to be further elucidated. However, evidence indicates that signaling through specific receptors may be responsible for apoptotic cell death in the CNS. For example, the expression of TNFa (Goodman et aI., 1990; Liu et aI., 1994; Shohami et aI., 1996) trophin receptor p7S NTR (Kokaia et aI., 1998 ) may be involved in apoptosis after cerebral ischemia and TBI in vivo. Moreover, limited data also indicate that Fas anti gen, which belongs to the family of cell surface proteins including TNF and p7S NTR , also may be involved in apoptotic cell death in vitro and in vivo. For example, increased Fas expression has been implicated in gluta mate-induced apoptotic cell death of CNS neurons in vitro (Li et aI., 1998) . In addition, a recent report sug gests that Fas and FasL may be overexpressed after N-methyl-D-aspartate injection in the hippocampus in vivo (Shin et aI., 1998) . Excessive excitatory amino acid release with subsequent neurotoxicity also has been de scribed in in vivo models of TBI (for review see Hayes et aI., 1992 , Faden et aI., 1989 Faden 1996; McIntosh et aI., 1998; Globus et aI., 1995; Katayama et aI., 1990; Nilsson et aI., 1990; Palmer et aI., 1993) and cerebral ischemia (for review see Rothman and Olney, 1989) . Therefore, excitotoxicity may be associated with in creased Fas expression seen in our experiments of TBI in vivo. Also notice that cortical impact injury may produce focal ischemia in the cortex ipsilateral to the injury site (Bryan et aI., 1995) . Thus, reduced cerebral blood flow also may have contributed to increased excitotoxicity and Fas expression in our experiments.
Our Western blotting data indicate that Fas protein is overexpressed in the ipsilateral cortex from IS minutes to 72 hours after the injury. Interestingly, Fas mRNA expression after experimental cerebral ischemia in the rat also is increased in the acute phase after the ischemic insult (Matsuyama et aI., 1995) . Because our data and a recent report (Newcomb et aI., 1999) suggest that apop totic-like morphologic features in cortical cells after con trolled cortical impact injury in the rat is most apparent up to 3 days after the trauma, it could be speculated that apoptotic cell death may indeed be mediated by Fas overexpression in the traumatically injured brain. Our results provide clear evidence of apoptotic-like morpho logic features (indicated by TUNEL staining) in Fas positive cortical cells after TBI in the rat.
Our immunohistochemical results suggest that Fas is expressed in astrocytes and neurons after TBI. A similar cellular distribution of Fas upregulation also has been described in different acute and chronic neurologic dis orders. Using in situ hybridization, Matsuyama et aI. (1994) report on Fas-immunoreactive neurons and glia from 6 to 24 hours after experimental cerebral ischemia in the rat. Further, increased expression of Fas also has been observed in glial cells after oxidative stress and hypoxia in vitro (Vogt et aI., 1998) , and in neurons and astrocytes of demyelinating lesions of multiple sclerosis patients (Dowling et aI., 1996) . These findings indicate that although Fas has been reported to be constitutively absent or weak in normal brain parenchyma (Park et aI., 1998) , brain is readily induced to express this receptor in a variety of pathologic stimuli.
In this report, we also provide evidence that the cyto toxic effector molecule FasL is upregulated after experi mental TBI in vivo. Our Western blotting results indicate that FasL is overexpressed from 15 minutes to 72 hours after the injury. Similar to our results, recent data suggest that FasL-induced apoptotic cell death occurs up to 5 days after experimental brain ischemia in vivo and in vitro (Martin-Villalba et aI., 1999) . In addition, FasL protein has been shown to be increased up to 3 days in the CSF of patients after head injury (Ertel et a!., 1997) . Taken together, these data indicate that early expression of FasL may have a pivotal role in the pathophysiologic mechanism of brain damage after acute brain injuries in vivo and in vitro.
Our immunohistochemical results of FasL expression suggest that FasL is posttraumatically overexpressed in neurons and astrocytes. Moreover, and in contrast to Fas, FasL protein expression also was upregulated in microg lial cells. Microglia has been proposed as a key cellular element in progressive tissue damage after brain isch emia (Stoll et aI., 1998) and head trauma (Aihara et aI., 1995) . However, the role of microglial FasL expression in mediating cellular damage after brain injuries remains to be further elucidated. For example, current data indi cate that FasL is not expressed in microglia after experi mental cerebral ischemia in vivo (Martin-Villalba et a!., 1999) . In contrast, a report provides evidence that oxi dative stress and hypoxia in vitro trigger FasL expression in microglial cells (Vogt et aI., 1998) , which may con tribute to apoptotic cellular damage. It has been shown that activated microglia can cross the blood-brain barrier and accumulate in the cortex after TBI in vivo (Aihara et aI., 1995) . Therefore, it could be speculated that FasL expressing microglia may migrate to Fas-expressing neu rons and astrocytes, which, through receptor-ligand in teraction, may result in subsequent apoptotic cell death.
Our data provide evidence that increased Fas and FasL immunoreacti vity, as detected by immunoblotting, was seen at 15 minutes after impact injury. Our immunohis tochemical results indicate that Fas and FasL are over expressed in neurons and astrocytes at this early time point after TBI. Previous studies also suggest that in creased expression of TNF-a, an antigen that belongs to the family of cell surface proteins including Fas, is over expressed in cortical neurons within I hour after TEl (Knoblach et aI., 1999; Shohami et aI., 1994) . However, we cannot exclude that other cells may have contributed to these early increases in Fas and FasL immunoreactiv ity in our experiments. For example, an immediate dis ruption of the blood-brain barrier, as seen after experi mental TBI (Dietrich et aI., 1994; Fukuda et aI., 1995) , may allow immune cells to enter the brain and may therefore contribute to the early increase of Fas and FasL immunoreactivity. In this regard, notice that Fas and FasL are expressed on blood leukocytes (Mincheff et a!., 1998) . Moreover, blood cells at sites of traumatically induced intracerebral hemorrhage also may have contrib uted to the early increase of Fas and FasL immunoreac tivity after TBI in vivo.
The interaction of Fas with its cell surface ligand (FasL) may be important for induction of apoptosis (Becher et aI., 1998; Nagata and Golstein, 1995) . Al though this study did not investigate the precise colocal ization of Fas-and FasL-positive cells after TBI, immu nohistochemical studies of Fas and FasL unambiguously showed that Fas and FasL are expressed in similar cor tical regions after TBI. Further, our study clearly dem onstrates the expression of Fas and FasL in TUNEL positive cells in the same cortical regions after TBI, sug gesting that the Fas/FasL system may play an important role in cortical apoptotic cell death after cortical impact injury. However, future studies using combined immu nohistochemical study for Fas and FasL have to further elucidate the exact interactions between Fas and its li gand after acute brain injuries in vivo.
The Fas ligand can be cleaved proteolytically from the cell surface by membrane-associated metalloproteinases, giving rise to a soluble form (sFasL) of the protein (Kay agaki et a!., 1995). Interestingly, sFasL may block apop tosis by inhibiting interaction between Fas and FasL on the cell surface (Cheng et a!., 1994) . However, sFasL also has been described to induce oligomerization of Fas on the target cell, resulting in activation of apoptosis (Matute-Bello et aI., 1999; Becher et aI., 1998) . Although our study did not determine the precise role of soluble FasL in possible neurodegeneration or neuroprotection after TBI, our data suggest that the membrane form of FasL may be involved in apoptosis after cortical impact injury. The interaction between the membrane-bound form of FasL and Fas antigen also has been shown to play a crucial role in mediating cytotoxicity after CNS ischemia in vivo (Martin-Villalba et a!., 1999) and in vitro (Vogt et aI., 1998) . Taken together, these results and our data suggest that Fas-carrying cells may indeed be a target of membrane-bound FasL attack after acute brain injuries in vivo. However, ongoing studies in our laboratory currently are investigating the precise role of sFasL on cellular damage or protection after TBI.
Our study failed to detect increased Fas and FasL ex pression in the hippocampus ipsilateral to the injury site from 15 minutes to 14 days after the trauma. This is in contrast to previous reports, where features of hippocam pal apoptosis have been described after lateral FP injury (McIntosh et aI., 1989) in vivo (Conti et aI., 1998; Yak ovlev et a!., 1997) . However, recent data suggest that there is no clear evidence of hippocampal cell death at early and late time points after unilateral cortical impact injury (Franz et aI., 1999) . Although higher magnitudes 676 R. BEER ET AL. of cortical impact injury than used in our study have been re ported to produce apoptotic hippocampal cell loss, the injury parameters in the current study did not result in overt apoptotic hippocampal damage (as indicated by TUNEL and Fas/FasL immunohistochemical study) at any of the time points examined. Moreover, another model of experimental TBI (i.e., central FP injury) may cause cortical neurodegeneration without evidence of hippocampal cell death (Taft et a!., 1992; . In ad dition, a report also indicates that cortical cells after cor tical impact injury eventually die, whereas hippocampal cells, although probably functionally impaired as indi cated by increased proteolysis, appear morphologically intact, even at later time points after lateral cortical im pact injury in vivo (Newcomb et a!., 1997) . Also notice that the presence or absence of hippocampal apoptotic cells after cortical impact injury may be attributable to the use of different impact angles (Colicos et aI., 1996) .
The precise pathway for Fas/FasL signaling in the brain has not yet been determined. However, recent re ports on Fas-mediated apoptosis indicate that Fas activa tion initially stimulates interleukin converting enzyme like proteases and then caspase 3-like proteases (Saas et a!., 1999; Cheema et a!., 1999) downstream to induce the morphologic changes and DNA fragmentation typical of apoptosis. Evidence shows that activation of caspase 3-like proteases contribute to neuronal apoptosis after FP injury (Yakovlev et aI., 1997) and controlled cortical impact injury in the rat (Pike et aI., 1998) .
In conclusion, our study demonstrates increased cor tical expression of Fas and FasL after TBI in the rat. Further, our findings indicate a pivotal role of the Fas-FasL pathway in the pathologic mechanism of apop totic neurodegeneration after cortical impact injury in vivo. Last, our results suggest that blockade of the Fas/ FasL system may reduce posttraumatic apoptosis and therefore may represent a new molecular target for thera peutic intervention after TBL
